Text Size

Entry Into Comprehensive Methadone Treatment Via Interim Maintenance

This study has been completed.
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by:
Friends Research Institute, Inc.
ClinicalTrials.gov Identifier:
NCT00712036
First received: July 2, 2008
Last updated: February 1, 2011
Last verified: February 2011
History of Changes
  Purpose

The purpose of the study is to determine whether one of three levels of counseling intensity will be associated with better treatment outcomes when combined with methadone maintenance treatment for heroin-addicted adults drawn from a methadone treatment program waiting list.


Condition Intervention
Opioid Dependency
 Behavioral: Interim
Behavioral: Comprehensive
Behavioral: Restored

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Entry Into Comprehensive Methadone Treatment Via Interim Maintenance

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Friends Research Institute, Inc.:

Primary Outcome Measures:
  • Opioid positive drug tests [ Time Frame: 4 and 12 months post-baseline ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • HIV risk behavior [ Time Frame: 4 and 12 months post-baseline ] [ Designated as safety issue: No ]
  • Treatment Retention [ Time Frame: 4 and 12 months post-baselin ] [ Designated as safety issue: No ]
  • Cost-benefit [ Time Frame: 12 months post-baseline ] [ Designated as safety issue: No ]
  • Cocaine positive tests [ Time Frame: 4 and 12 months post-baseline ] [ Designated as safety issue: No ]

Estimated Enrollment: 300
Study Start Date: June 2008
Study Completion Date: January 2011
Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Interim
Methadone maintenance for up to 4 months with emergency counseling only for individuals on program waiting lists.
 Behavioral: Interim
Methadone maintenance with emergency counseling only for up to 4 months
Active Comparator: Comprehensive
Methadone Treatment provided with counseling as usual.
 Behavioral: Comprehensive
Methadone treatment with counseling as usual
Active Comparator: Restored
Methadone Treatment with counseling provided by a clinician with a lower caseload than counseling as usual.
 Behavioral: Restored
Methadone maintenance with counseling provided by a clinician with a lower than usual caseload

Detailed Description:

Waiting lists for methadone treatment programs persist, and new and more effective approaches for expanding treatment access and improving outcomes for heroin dependent individuals are needed. Recently completed research demonstrated that so-called "Interim Methadone Maintenance" (i.e., methadone with crisis counseling only, for individuals on waiting lists) was associated with greater entry into methadone treatment, less self-reported heroin and cocaine use, lower rates of opioid-positive drug tests, and lower rates of self-reported crime. The present study will build on this work by comparing three levels of counseling provided with methadone treatment: 1)"Interim" Methadone Treatment; 2) "Comprehensive" Methadone Treatment (which is the name for the usual amount of counseling provided, i.e., about once per week) and; 3)"Restored" Methadone Treatment in which the counselors will have a lower case load and will be able to provide more attention to their patients.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • adult
  • meets criteria for methadone maintenance
  • unable to gain admission to methadone program within 14 days

Exclusion Criteria:

  • pregnant
  • acute medical or psychiatric illness
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00712036

Locations
United States, Maryland
Friends Research Institute
Baltimore, Maryland, United States, 21201
Sponsors and Collaborators
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Robert P Schwartz, M.D. Friends Research Institute, Inc.
  More Information

Publications:

Responsible Party: Robert P. Schwartz, M.D., Friends Research Institute
ClinicalTrials.gov Identifier: NCT00712036     History of Changes
Other Study ID Numbers: DA R01 13636
Study First Received: July 2, 2008
Last Updated: February 1, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Friends Research Institute, Inc.:
Heroin dependence
Interim Methadone Treatment
Counseling

Additional relevant MeSH terms:
Methadone
Analgesics, Opioid
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Pharmacologic Actions
 Central Nervous System Agents
Therapeutic Uses
Central Nervous System Depressants
Antitussive Agents
Respiratory System Agents
Narcotics

ClinicalTrials.gov processed this record on May 16, 2013